Concepts (328)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metal Nanoparticles | 20 | 2025 | 26 | 7.220 |
Why?
|
| Nanostructures | 15 | 2023 | 40 | 6.630 |
Why?
|
| Gold | 18 | 2025 | 38 | 5.800 |
Why?
|
| Air Pollutants | 6 | 2020 | 8 | 1.860 |
Why?
|
| Nanoparticles | 5 | 2022 | 104 | 1.830 |
Why?
|
| Mining | 3 | 2020 | 41 | 1.750 |
Why?
|
| Silver | 10 | 2023 | 15 | 1.670 |
Why?
|
| Inhalation Exposure | 8 | 2021 | 8 | 1.660 |
Why?
|
| Occupational Exposure | 5 | 2019 | 35 | 1.660 |
Why?
|
| Citric Acid | 6 | 2022 | 8 | 1.650 |
Why?
|
| Dust | 7 | 2021 | 15 | 1.590 |
Why?
|
| Silicon Dioxide | 8 | 2019 | 10 | 1.580 |
Why?
|
| Environmental Exposure | 4 | 2021 | 45 | 1.510 |
Why?
|
| Animals | 29 | 2024 | 1081 | 1.460 |
Why?
|
| Epithelial Cells | 4 | 2020 | 14 | 1.360 |
Why?
|
| Lung | 14 | 2024 | 70 | 1.320 |
Why?
|
| Humans | 42 | 2025 | 14537 | 1.300 |
Why?
|
| Nanotechnology | 2 | 2021 | 28 | 1.260 |
Why?
|
| Risk Assessment | 10 | 2021 | 225 | 1.170 |
Why?
|
| Occupational Diseases | 4 | 2016 | 40 | 1.170 |
Why?
|
| Toxicology | 3 | 2017 | 4 | 1.140 |
Why?
|
| Neoplasms | 2 | 2020 | 147 | 1.120 |
Why?
|
| Toxicity Tests | 6 | 2020 | 7 | 1.100 |
Why?
|
| Particle Size | 14 | 2023 | 73 | 1.070 |
Why?
|
| Environmental Monitoring | 5 | 2018 | 20 | 1.060 |
Why?
|
| Cell Survival | 7 | 2025 | 48 | 0.940 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 90 | 0.860 |
Why?
|
| Asthma | 1 | 2023 | 33 | 0.860 |
Why?
|
| Surface Properties | 8 | 2021 | 46 | 0.850 |
Why?
|
| Caspase 7 | 2 | 2025 | 3 | 0.830 |
Why?
|
| Adenocarcinoma | 1 | 2022 | 10 | 0.810 |
Why?
|
| Antioxidants | 5 | 2013 | 26 | 0.800 |
Why?
|
| Mutagens | 2 | 2017 | 5 | 0.790 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 47 | 0.770 |
Why?
|
| Polyethylene Glycols | 5 | 2025 | 49 | 0.770 |
Why?
|
| Cell Line | 5 | 2021 | 93 | 0.770 |
Why?
|
| Nanomedicine | 2 | 2020 | 24 | 0.740 |
Why?
|
| Drug Design | 1 | 2021 | 29 | 0.740 |
Why?
|
| Asbestos | 8 | 2010 | 10 | 0.730 |
Why?
|
| Lead | 1 | 2021 | 33 | 0.720 |
Why?
|
| Respiratory System | 1 | 2020 | 9 | 0.710 |
Why?
|
| Waste Disposal Facilities | 1 | 2020 | 9 | 0.710 |
Why?
|
| Drug Delivery Systems | 2 | 2022 | 252 | 0.710 |
Why?
|
| High-Throughput Screening Assays | 1 | 2020 | 11 | 0.700 |
Why?
|
| Environmental Health | 2 | 2016 | 6 | 0.650 |
Why?
|
| Plant Extracts | 6 | 2013 | 32 | 0.640 |
Why?
|
| Occupational Health | 2 | 2016 | 24 | 0.630 |
Why?
|
| Caveolae | 1 | 2018 | 1 | 0.630 |
Why?
|
| Endocytosis | 1 | 2018 | 6 | 0.630 |
Why?
|
| Hepatocytes | 2 | 2016 | 19 | 0.630 |
Why?
|
| Gene Expression Profiling | 2 | 2023 | 41 | 0.630 |
Why?
|
| RNA | 2 | 2017 | 26 | 0.620 |
Why?
|
| Rats | 13 | 2023 | 130 | 0.590 |
Why?
|
| Salmonella typhimurium | 2 | 2017 | 4 | 0.580 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 77 | 0.570 |
Why?
|
| Plant Preparations | 2 | 2008 | 2 | 0.550 |
Why?
|
| Mineral Fibers | 4 | 2019 | 7 | 0.540 |
Why?
|
| Health Occupations | 1 | 2016 | 4 | 0.540 |
Why?
|
| Drug Contamination | 2 | 2014 | 3 | 0.530 |
Why?
|
| Conservation of Energy Resources | 1 | 2016 | 1 | 0.530 |
Why?
|
| Renewable Energy | 1 | 2016 | 1 | 0.530 |
Why?
|
| Environmental Pollution | 1 | 2016 | 2 | 0.530 |
Why?
|
| Scleroderma, Systemic | 2 | 2015 | 43 | 0.530 |
Why?
|
| Lipid Peroxidation | 6 | 2013 | 7 | 0.520 |
Why?
|
| Kidney | 1 | 2016 | 46 | 0.510 |
Why?
|
| Hazardous Substances | 1 | 2015 | 3 | 0.510 |
Why?
|
| Kinetics | 4 | 2022 | 65 | 0.500 |
Why?
|
| DNA Methylation | 1 | 2015 | 19 | 0.490 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2015 | 35 | 0.480 |
Why?
|
| Models, Biological | 1 | 2015 | 77 | 0.470 |
Why?
|
| Population Surveillance | 1 | 2016 | 325 | 0.470 |
Why?
|
| Plants, Medicinal | 3 | 2012 | 7 | 0.470 |
Why?
|
| Mass Screening | 1 | 2016 | 245 | 0.470 |
Why?
|
| Minerals | 3 | 2015 | 3 | 0.450 |
Why?
|
| Microbiota | 1 | 2014 | 30 | 0.440 |
Why?
|
| Particulate Matter | 3 | 2021 | 5 | 0.430 |
Why?
|
| Developing Countries | 2 | 2016 | 400 | 0.420 |
Why?
|
| Microscopy, Electron, Transmission | 4 | 2017 | 18 | 0.410 |
Why?
|
| Biomarkers | 3 | 2019 | 327 | 0.400 |
Why?
|
| Xenobiotics | 1 | 2012 | 4 | 0.390 |
Why?
|
| Developed Countries | 1 | 2012 | 24 | 0.390 |
Why?
|
| South Africa | 10 | 2020 | 7596 | 0.390 |
Why?
|
| Oxidants | 2 | 2009 | 6 | 0.380 |
Why?
|
| Tissue Distribution | 6 | 2020 | 10 | 0.370 |
Why?
|
| Medicine, African Traditional | 2 | 2008 | 25 | 0.370 |
Why?
|
| Inflammation | 3 | 2009 | 104 | 0.360 |
Why?
|
| Parenteral Nutrition | 1 | 2009 | 1 | 0.330 |
Why?
|
| Solubility | 2 | 2022 | 51 | 0.320 |
Why?
|
| Air Pollutants, Occupational | 2 | 2006 | 4 | 0.320 |
Why?
|
| Magnoliopsida | 1 | 2008 | 3 | 0.310 |
Why?
|
| Perception | 1 | 2009 | 42 | 0.310 |
Why?
|
| Lung Diseases | 2 | 2005 | 29 | 0.300 |
Why?
|
| Safety | 2 | 2020 | 34 | 0.300 |
Why?
|
| Lipid Peroxides | 4 | 2009 | 6 | 0.280 |
Why?
|
| Comet Assay | 3 | 2017 | 3 | 0.280 |
Why?
|
| Coal Mining | 1 | 2006 | 1 | 0.270 |
Why?
|
| Silicosis | 1 | 2006 | 8 | 0.270 |
Why?
|
| Oxidative Stress | 2 | 2013 | 19 | 0.270 |
Why?
|
| Amines | 2 | 2025 | 2 | 0.270 |
Why?
|
| Asbestos, Crocidolite | 6 | 1999 | 7 | 0.260 |
Why?
|
| Cricetulus | 2 | 2017 | 2 | 0.250 |
Why?
|
| CHO Cells | 2 | 2017 | 3 | 0.250 |
Why?
|
| Education | 1 | 2005 | 22 | 0.250 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2020 | 7 | 0.250 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2023 | 63 | 0.250 |
Why?
|
| Coal | 2 | 2018 | 2 | 0.240 |
Why?
|
| Spheroids, Cellular | 1 | 2025 | 3 | 0.240 |
Why?
|
| HEK293 Cells | 2 | 2016 | 39 | 0.240 |
Why?
|
| Lymphocytes | 1 | 2004 | 20 | 0.240 |
Why?
|
| DNA | 1 | 2004 | 73 | 0.230 |
Why?
|
| Catalysis | 2 | 2021 | 6 | 0.230 |
Why?
|
| Nanotubes, Carbon | 1 | 2024 | 9 | 0.220 |
Why?
|
| Lung Neoplasms | 2 | 2025 | 32 | 0.220 |
Why?
|
| Manufactured Materials | 2 | 2018 | 2 | 0.220 |
Why?
|
| Zinc Fingers | 1 | 2023 | 1 | 0.210 |
Why?
|
| Male | 12 | 2023 | 6754 | 0.210 |
Why?
|
| U937 Cells | 2 | 2020 | 4 | 0.210 |
Why?
|
| Citrates | 1 | 2022 | 4 | 0.210 |
Why?
|
| Keratinocytes | 1 | 2022 | 2 | 0.210 |
Why?
|
| Caco-2 Cells | 1 | 2022 | 10 | 0.200 |
Why?
|
| Titanium | 1 | 2022 | 1 | 0.200 |
Why?
|
| Environmental Pollutants | 2 | 2015 | 16 | 0.200 |
Why?
|
| Nanofibers | 1 | 2022 | 13 | 0.200 |
Why?
|
| Metabolic Clearance Rate | 3 | 2020 | 11 | 0.190 |
Why?
|
| Drug Stability | 1 | 2021 | 13 | 0.190 |
Why?
|
| Reference Standards | 1 | 2021 | 29 | 0.190 |
Why?
|
| Malawi | 1 | 2021 | 87 | 0.180 |
Why?
|
| Cell Death | 1 | 2020 | 2 | 0.180 |
Why?
|
| DNA Damage | 3 | 2008 | 12 | 0.180 |
Why?
|
| Chemical Phenomena | 2 | 2017 | 6 | 0.180 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 9 | 0.180 |
Why?
|
| Drug Discovery | 1 | 2020 | 23 | 0.180 |
Why?
|
| Cell Proliferation | 1 | 2020 | 45 | 0.180 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2020 | 2 | 0.180 |
Why?
|
| Adenosine Triphosphate | 1 | 2020 | 8 | 0.180 |
Why?
|
| Fluorescent Dyes | 1 | 2020 | 13 | 0.180 |
Why?
|
| Free Radicals | 4 | 2013 | 6 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 125 | 0.170 |
Why?
|
| Materials Science | 1 | 2020 | 1 | 0.170 |
Why?
|
| Pulmonary Fibrosis | 1 | 2000 | 9 | 0.170 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 217 | 0.170 |
Why?
|
| Mutagenicity Tests | 2 | 2017 | 3 | 0.170 |
Why?
|
| Animal Use Alternatives | 1 | 2019 | 1 | 0.160 |
Why?
|
| Endpoint Determination | 1 | 2019 | 8 | 0.160 |
Why?
|
| Hep G2 Cells | 2 | 2016 | 14 | 0.160 |
Why?
|
| Chlorpromazine | 1 | 2018 | 1 | 0.160 |
Why?
|
| Colloids | 1 | 2018 | 1 | 0.160 |
Why?
|
| Genistein | 1 | 2018 | 1 | 0.160 |
Why?
|
| Bronchi | 1 | 2018 | 5 | 0.160 |
Why?
|
| Volatile Organic Compounds | 1 | 2018 | 3 | 0.160 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2018 | 1 | 0.160 |
Why?
|
| Artemia | 1 | 2018 | 1 | 0.160 |
Why?
|
| Lakes | 1 | 2018 | 3 | 0.160 |
Why?
|
| Water Pollutants, Chemical | 1 | 2018 | 3 | 0.160 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 46 | 0.150 |
Why?
|
| Water | 1 | 2018 | 22 | 0.150 |
Why?
|
| Models, Theoretical | 1 | 2018 | 80 | 0.150 |
Why?
|
| Cricetinae | 2 | 2013 | 3 | 0.150 |
Why?
|
| Chelating Agents | 2 | 1999 | 11 | 0.150 |
Why?
|
| Reactive Oxygen Species | 4 | 2013 | 23 | 0.150 |
Why?
|
| DNA, Complementary | 1 | 2017 | 17 | 0.140 |
Why?
|
| Microwaves | 1 | 1997 | 3 | 0.140 |
Why?
|
| Crystallization | 3 | 2008 | 8 | 0.140 |
Why?
|
| Residence Characteristics | 1 | 2017 | 57 | 0.140 |
Why?
|
| Preservatives, Pharmaceutical | 1 | 2017 | 1 | 0.140 |
Why?
|
| Micronucleus Tests | 1 | 2017 | 2 | 0.140 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 4 | 0.140 |
Why?
|
| Chromosome Aberrations | 1 | 2017 | 5 | 0.140 |
Why?
|
| Biological Transport | 1 | 2017 | 11 | 0.140 |
Why?
|
| False Positive Reactions | 1 | 2017 | 17 | 0.140 |
Why?
|
| Environmental Policy | 1 | 2016 | 1 | 0.130 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1422 | 0.130 |
Why?
|
| Exocytosis | 1 | 2016 | 1 | 0.130 |
Why?
|
| Ferric Compounds | 2 | 1993 | 5 | 0.120 |
Why?
|
| Oxides | 1 | 2015 | 1 | 0.120 |
Why?
|
| Tungsten | 1 | 2015 | 1 | 0.120 |
Why?
|
| Ferrous Compounds | 2 | 1993 | 4 | 0.120 |
Why?
|
| Phytotherapy | 2 | 2005 | 6 | 0.120 |
Why?
|
| Biological Availability | 1 | 2015 | 43 | 0.120 |
Why?
|
| Child | 1 | 2021 | 2242 | 0.120 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2019 | 329 | 0.120 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2014 | 3 | 0.120 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2014 | 8 | 0.120 |
Why?
|
| Microscopy | 1 | 2014 | 21 | 0.120 |
Why?
|
| Free Radical Scavengers | 2 | 2004 | 6 | 0.120 |
Why?
|
| Aerosols | 3 | 2020 | 7 | 0.120 |
Why?
|
| Gold Compounds | 1 | 2014 | 1 | 0.120 |
Why?
|
| Middle Aged | 2 | 2015 | 3601 | 0.110 |
Why?
|
| Ethylene Oxide | 1 | 2014 | 1 | 0.110 |
Why?
|
| Formaldehyde | 1 | 2014 | 1 | 0.110 |
Why?
|
| X-Rays | 1 | 2014 | 1 | 0.110 |
Why?
|
| Plasma Gases | 1 | 2014 | 1 | 0.110 |
Why?
|
| Filtration | 1 | 2014 | 3 | 0.110 |
Why?
|
| Endotoxins | 1 | 2014 | 6 | 0.110 |
Why?
|
| Molecular Structure | 1 | 2014 | 32 | 0.110 |
Why?
|
| Adult | 3 | 2018 | 5913 | 0.110 |
Why?
|
| Electric Impedance | 1 | 2013 | 8 | 0.110 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 20 | 0.110 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 7 | 0.110 |
Why?
|
| Syzygium | 1 | 2013 | 1 | 0.110 |
Why?
|
| Polyphenols | 1 | 2013 | 3 | 0.110 |
Why?
|
| Fabaceae | 1 | 2013 | 2 | 0.110 |
Why?
|
| Cadmium | 1 | 1993 | 1 | 0.110 |
Why?
|
| Dichlorodiphenyldichloroethane | 1 | 2013 | 1 | 0.110 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2013 | 1 | 0.110 |
Why?
|
| Protective Agents | 1 | 2013 | 1 | 0.110 |
Why?
|
| Heterocyclic Compounds | 1 | 1993 | 3 | 0.110 |
Why?
|
| Acetylcysteine | 1 | 2013 | 4 | 0.110 |
Why?
|
| Time Factors | 1 | 2014 | 507 | 0.110 |
Why?
|
| Plant Bark | 2 | 2013 | 4 | 0.110 |
Why?
|
| DDT | 1 | 2013 | 30 | 0.100 |
Why?
|
| Tuberculosis | 1 | 2019 | 543 | 0.100 |
Why?
|
| Microsomes | 3 | 1987 | 4 | 0.100 |
Why?
|
| Food Contamination | 1 | 2012 | 3 | 0.100 |
Why?
|
| Risk Factors | 1 | 2016 | 1475 | 0.100 |
Why?
|
| Administration, Inhalation | 2 | 2022 | 5 | 0.100 |
Why?
|
| International Cooperation | 1 | 2012 | 50 | 0.100 |
Why?
|
| Insecticides | 1 | 2013 | 135 | 0.090 |
Why?
|
| Forecasting | 1 | 2010 | 20 | 0.080 |
Why?
|
| Oxygen | 2 | 2004 | 25 | 0.080 |
Why?
|
| Cyclic N-Oxides | 1 | 2009 | 1 | 0.080 |
Why?
|
| Spin Labels | 1 | 2009 | 1 | 0.080 |
Why?
|
| Isoprostanes | 1 | 2009 | 1 | 0.080 |
Why?
|
| Solutions | 1 | 2009 | 2 | 0.080 |
Why?
|
| Malondialdehyde | 1 | 2009 | 3 | 0.080 |
Why?
|
| Vitamin E | 1 | 2009 | 9 | 0.080 |
Why?
|
| Venoms | 1 | 2009 | 2 | 0.080 |
Why?
|
| Methanol | 1 | 2008 | 1 | 0.080 |
Why?
|
| Plant Poisoning | 1 | 2008 | 1 | 0.080 |
Why?
|
| Toxins, Biological | 1 | 2008 | 1 | 0.080 |
Why?
|
| Indicators and Reagents | 1 | 2008 | 4 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 9 | 0.080 |
Why?
|
| Solvents | 1 | 2008 | 15 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2008 | 16 | 0.080 |
Why?
|
| Interferon-alpha | 1 | 2008 | 15 | 0.080 |
Why?
|
| Intensive Care Units | 1 | 2009 | 66 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 44 | 0.080 |
Why?
|
| Monocytes | 1 | 2008 | 27 | 0.080 |
Why?
|
| Injections, Intravenous | 2 | 2018 | 11 | 0.080 |
Why?
|
| Young Adult | 1 | 2015 | 2498 | 0.070 |
Why?
|
| Iron | 2 | 1999 | 32 | 0.070 |
Why?
|
| Cations | 1 | 1987 | 7 | 0.070 |
Why?
|
| Computer Simulation | 2 | 2020 | 56 | 0.070 |
Why?
|
| Female | 3 | 2018 | 9103 | 0.070 |
Why?
|
| Early Diagnosis | 1 | 2006 | 82 | 0.060 |
Why?
|
| Prostatic Hyperplasia | 1 | 2005 | 1 | 0.060 |
Why?
|
| Prostatitis | 1 | 2005 | 2 | 0.060 |
Why?
|
| Spectroscopy, Mossbauer | 2 | 1997 | 2 | 0.060 |
Why?
|
| Hydrogen Peroxide | 2 | 1997 | 11 | 0.060 |
Why?
|
| Needs Assessment | 1 | 2005 | 29 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 176 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 39 | 0.060 |
Why?
|
| A549 Cells | 1 | 2025 | 4 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2025 | 4 | 0.060 |
Why?
|
| Cell Cycle | 1 | 2025 | 6 | 0.060 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2004 | 2 | 0.060 |
Why?
|
| Hydroxyl Radical | 1 | 2004 | 3 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2025 | 62 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2004 | 6 | 0.060 |
Why?
|
| Organic Chemicals | 1 | 2024 | 3 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 20 | 0.060 |
Why?
|
| Swine | 1 | 2024 | 49 | 0.060 |
Why?
|
| Laboratories | 1 | 2024 | 47 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 99 | 0.050 |
Why?
|
| Plant Proteins | 1 | 2023 | 4 | 0.050 |
Why?
|
| Reactive Nitrogen Species | 1 | 2003 | 1 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2023 | 7 | 0.050 |
Why?
|
| Microsomes, Liver | 1 | 1983 | 9 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 293 | 0.050 |
Why?
|
| Carbon | 1 | 2022 | 5 | 0.050 |
Why?
|
| Oxidation-Reduction | 2 | 1997 | 24 | 0.050 |
Why?
|
| Software | 1 | 2021 | 37 | 0.050 |
Why?
|
| Ascorbic Acid | 2 | 2013 | 13 | 0.050 |
Why?
|
| Research Design | 1 | 2021 | 124 | 0.040 |
Why?
|
| Asbestosis | 1 | 1999 | 5 | 0.040 |
Why?
|
| Risk Management | 1 | 2019 | 4 | 0.040 |
Why?
|
| Binding Sites | 1 | 1999 | 43 | 0.040 |
Why?
|
| Body Burden | 1 | 2019 | 1 | 0.040 |
Why?
|
| Acinar Cells | 1 | 2019 | 1 | 0.040 |
Why?
|
| Quartz | 1 | 1999 | 1 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 1999 | 1 | 0.040 |
Why?
|
| Asbestos, Serpentine | 1 | 1999 | 1 | 0.040 |
Why?
|
| Reducing Agents | 1 | 1999 | 1 | 0.040 |
Why?
|
| Chemistry, Physical | 1 | 1999 | 2 | 0.040 |
Why?
|
| Benzene Derivatives | 1 | 2018 | 1 | 0.040 |
Why?
|
| Toluene | 1 | 2018 | 1 | 0.040 |
Why?
|
| Xylenes | 1 | 2018 | 1 | 0.040 |
Why?
|
| Benzene | 1 | 2018 | 2 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2019 | 4 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 2019 | 6 | 0.040 |
Why?
|
| Adsorption | 1 | 1999 | 6 | 0.040 |
Why?
|
| Pneumoconiosis | 1 | 1999 | 2 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 1999 | 6 | 0.040 |
Why?
|
| Immunity | 1 | 2019 | 10 | 0.040 |
Why?
|
| Erythrocytes | 1 | 1999 | 11 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 1999 | 11 | 0.040 |
Why?
|
| Phagocytosis | 1 | 1999 | 15 | 0.040 |
Why?
|
| Organ Size | 1 | 2019 | 34 | 0.040 |
Why?
|
| Rabbits | 1 | 1999 | 35 | 0.040 |
Why?
|
| Macrophages | 1 | 2019 | 15 | 0.040 |
Why?
|
| Salinity | 1 | 2018 | 3 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 65 | 0.040 |
Why?
|
| Blood Coagulation | 1 | 2018 | 29 | 0.040 |
Why?
|
| Aldehydes | 1 | 1997 | 2 | 0.040 |
Why?
|
| Hot Temperature | 1 | 1997 | 28 | 0.040 |
Why?
|
| Rats, Inbred Strains | 2 | 1987 | 3 | 0.030 |
Why?
|
| Half-Life | 1 | 2014 | 22 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 1993 | 1 | 0.030 |
Why?
|
| Lethal Dose 50 | 1 | 1993 | 3 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2013 | 10 | 0.030 |
Why?
|
| Mitochondria, Liver | 1 | 2013 | 1 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 2013 | 2 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2013 | 7 | 0.030 |
Why?
|
| Iron Chelating Agents | 1 | 1993 | 7 | 0.030 |
Why?
|
| Apoptosis | 1 | 2013 | 40 | 0.030 |
Why?
|
| Mice | 1 | 2013 | 135 | 0.030 |
Why?
|
| Butylated Hydroxytoluene | 1 | 1987 | 1 | 0.020 |
Why?
|
| Glutathione | 1 | 1987 | 4 | 0.020 |
Why?
|
| NADP | 1 | 1987 | 1 | 0.020 |
Why?
|
| Magnesium | 1 | 1987 | 6 | 0.020 |
Why?
|
| Manganese | 1 | 1987 | 11 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1987 | 63 | 0.020 |
Why?
|
| Calcium | 1 | 1987 | 49 | 0.020 |
Why?
|
| Cyclooxygenase 1 | 1 | 2005 | 1 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2005 | 2 | 0.020 |
Why?
|
| Phenotype | 1 | 2004 | 158 | 0.010 |
Why?
|
| Alleles | 1 | 2004 | 143 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2004 | 480 | 0.010 |
Why?
|